CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)

CJC-1295 & GHRP-6 Blend (10mg)

Name: CJC-1295 & GHRP-6 Blend (10mg) - Planex Supplies
SKU: CJC-1295 & GHRP-6 Blend (10mg)
Price: 86.00 USD
Availability: InStock

$86.00

Buy the premium CJC-1295 & GHRP-6 Peptide Blend from Planex Supplies. This advanced composite research formulation pairs a tetra-substituted GHRH mimetic with a synthetic ghrelin receptor agonist to investigate downstream neuroendocrine kinetics, somatotroph cell proliferation, and neuroprotective cell-survival pathways. Every batch is independently USA-tested with transparent, documented Certificates of Analysis (COAs) to guarantee standard-setting laboratory integrity.

SKU: CJC-1295 & GHRP-6 Blend (10mg) Category: Peptide Blends Tags: Buy Peptides Online, CD36 Pathway, CJC-1295, GHRH Mimetic, GHRP-6, Lab Supplies, Neuroprotection, Peptide Blend, Pituitary Research, Planex Supplies, Research Peptides, Secretagogue, USA Tested

Description
Reviews (0)

Synergistic Dual-Pathway Growth Hormone Secretagogue Research

The CJC-1295 & GHRP-6 Peptide Blend from Planex Supplies brings together two distinct molecular structures widely studied for their synergistic impact on the central nervous system, specifically within the pituitary gland and hypothalamus. While CJC-1295 targets the Growth Hormone-Releasing Hormone (GHRH) receptor pathway, GHRP-6 acts on the growth hormone secretagogue receptor (GHS-R1a) via ghrelin molecular mimicry. Together, they provide a powerful framework for researching concurrent pulsatile and baseline neuroendocrine signaling in preclinical laboratory models.

Comprehensive Technical Specifications:

CJC-1295 (Modified GRF 1-29) (Note: Formulated without DAC for precise pulsatile simulation)

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: 3367.954 g/mol
Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2

GHRP-6 (Growth Hormone Releasing Peptide 6)

Molecular Formula: C₄₆H₅₆N₁₂O₆
Molecular Weight: 873.032 g/mol
Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys

Key Areas of Scientific Research & Mechanisms:

Enzymatic Resistance & Somatotroph Proliferation: CJC-1295 is an engineered analog representing the functional 29-amino acid chain of endogenous GHRH. It incorporates specific substitutions at the 2nd, 8th, 15th, and 27th positions to dramatically enhance resistance against dipeptidyl peptidase-4 (DPP-4) enzymatic degradation. Preclinical data indicates that CJC-1295 upregulates total pituitary RNA and GH mRNA, indicating localized somatotroph cell proliferation.
Receptor Mimicry & Systemic Biomarkers: GHRP-6, an opioid analog of Met-enkephalin designed without traditional opioid activity, targets GHS-R1a. Combined exposures demonstrate that GHRP-6 sustains baseline hormone levels, while CJC-1295 drives high-amplitude spikes, elevating mean GH concentrations by 2- to 10-fold under study conditions. This sustained action leads to a documented 46% increase in mean GH levels and a 45% increase in anabolic mediators such as Insulin-Like Growth Factor 1 (IGF-1).
Nervous Tissue Protection & Cell Survival: Investigative models show that a one-week introduction of GHRP-6 promotes a significant increase in IGF-1 mRNA expression within the hypothalamus, cerebellum, and hippocampus. This local upregulation triggers intracellular phosphatidylinositol kinase survival pathways. Studies highlight a clear shift toward cell survival over apoptosis, driven by the stimulation/phosphorylation of Akt and Bad alongside an increase in anti-apoptotic Bcl-2 proteins.
CD36 Receptor Preference & Cytoprotection: Beyond neuroendocrine pathways, GHRP-6 demonstrates a unique affinity for CD36 receptors, which modulate fatty acid absorption, immune responses, and macrophage phagocytosis. Researchers explore this pathway in cardiovascular and ischemia-reperfusion models to evaluate the peptide’s ability to limit myocardial tissue scarring and regulate angiogenesis.

The Planex Supplies Quality Standard

At Planex Supplies, we prioritize strict quality control protocols to preserve the accuracy and reproducibility of your laboratory findings. Our CJC-1295 + GHRP-6 blend is synthesized to high technical tolerances and validated using high-performance liquid chromatography (HPLC). Every single batch is backed by a fully documented, third-party Certificate of Analysis (COA) issued by an independent laboratory in the USA.

Verified Purity: ≥ 99% purity guaranteed through mass spectrometry and HPLC profiling.
USA Vetted: Independently verified to ensure structural identity, correct molecular mass, and zero cross-contaminants.
Research Use Only: This compound is synthesized exclusively for in vitro laboratory experimentation and preclinical evaluation.